SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IGEN International
IGEN 0.00010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Perry who wrote (279)3/7/1998 12:18:00 AM
From: John Zwiener  Read Replies (1) of 1025
 
The stock is only at 27, with the bid and ask higher. Granted it's 5
times higher than 8 months ago, but there is a long way to go before
it hits the very conservative minimum of 40. I feel the minimum should
be higher, but Igen didn't reveal the terms of the Pfizer deal (which I
suppose to be possibly to be as big as the Roche/BMG deal---I'm
referring to the potential of the high thru-put for pharmaceutical
screening purposes. There is a lot of competition here, but the
casual reference to making new tests in days instead of months is
very big. To my way of thinking, this ability will save major pharm. co.
tens and hundreds of millions in research, by quickly directing the focus in the right direction).

Price up, why?
The potential of the latest press release.
New deal pending.
Roche settling with Igen, in Igen's favor.
New attention by that analyst who says it's his best idea.

though I am pleased with this price run, I still am bored with this
stock because it continues to do what I have expected. I still expect
it to be higher in the long run.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext